A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer Meeting Abstract
| Authors: | Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E. |
| Abstract Title: | A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2014 Jan 16-18 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-01-01 |
| Language: | English |
| ACCESSION: | WOS:000333682100059 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.3_suppl.52 |
| Notes: | Meeting Abstract: 52 -- Gastrointestinal Cancers Symposium -- JAN 16-18, 2014 -- San Francisco, CA -- S -- Source: Wos |
